Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?
Derijks
Luc J J
LJ
Department of Clinical Pharmacy, Máxima Medical Center, PO Box 7777, 5500 MB Veldhoven, The Netherlands. l.derijks@mmc.nl
Hommes
Daniel W
DW
D000963:Antimetabolites / Q000097:blood / Q000627:therapeutic use*; D001379:Azathioprine / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000379:methods; D005838:Genotype; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000188:drug therapy*; D008780:Methyltransferases / Q000235:genetics; D011755:Pyrophosphatases / Q000235:genetics; D013866:Thioguanine / Q000097:blood / Q000627:therapeutic use*; D000097630:Inosine Triphosphatase
D000963:Antimetabolites; D001379:Azathioprine; D008780:Methyltransferases; D011755:Pyrophosphatases; D013866:Thioguanine; C022745:thiopurine methyltransferase; C511829:ITPA protein, human; D000097630:Inosine Triphosphatase